1. Home
  2. FORM vs AMRX Comparison

FORM vs AMRX Comparison

Compare FORM & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FORM
  • AMRX
  • Stock Information
  • Founded
  • FORM 1993
  • AMRX 2002
  • Country
  • FORM United States
  • AMRX United States
  • Employees
  • FORM N/A
  • AMRX N/A
  • Industry
  • FORM Semiconductors
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FORM Technology
  • AMRX Health Care
  • Exchange
  • FORM Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • FORM 3.0B
  • AMRX 2.5B
  • IPO Year
  • FORM N/A
  • AMRX N/A
  • Fundamental
  • Price
  • FORM $48.59
  • AMRX $7.97
  • Analyst Decision
  • FORM Buy
  • AMRX Strong Buy
  • Analyst Count
  • FORM 8
  • AMRX 5
  • Target Price
  • FORM $55.38
  • AMRX $10.00
  • AVG Volume (30 Days)
  • FORM 584.7K
  • AMRX 1.1M
  • Earning Date
  • FORM 02-05-2025
  • AMRX 11-08-2024
  • Dividend Yield
  • FORM N/A
  • AMRX N/A
  • EPS Growth
  • FORM N/A
  • AMRX N/A
  • EPS
  • FORM 1.72
  • AMRX N/A
  • Revenue
  • FORM $742,279,000.00
  • AMRX $2,680,420,000.00
  • Revenue This Year
  • FORM $17.59
  • AMRX $17.86
  • Revenue Next Year
  • FORM $8.39
  • AMRX $3.90
  • P/E Ratio
  • FORM $25.46
  • AMRX N/A
  • Revenue Growth
  • FORM 12.31
  • AMRX 12.32
  • 52 Week Low
  • FORM $37.21
  • AMRX $5.01
  • 52 Week High
  • FORM $63.63
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • FORM 67.54
  • AMRX 42.36
  • Support Level
  • FORM $41.93
  • AMRX $7.68
  • Resistance Level
  • FORM $43.73
  • AMRX $8.18
  • Average True Range (ATR)
  • FORM 1.71
  • AMRX 0.29
  • MACD
  • FORM 0.55
  • AMRX -0.04
  • Stochastic Oscillator
  • FORM 97.99
  • AMRX 25.41

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc designs, develops, manufactures, sells, and supports semiconductor probe card products. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: